EPISODE · Nov 24, 2025 · 1H 19M
Reversing Vascular Plaque: The Truth About Cholesterol with Lipidologist Dr. William Cromwell
from The Ultimate Asset · host Velocity Health
Heart disease is the #1 killer in the world, but are we measuring the right markers?In this episode of The Ultimate Asset, Dr. Deep sits down with Dr. William Cromwell, a world-renowned lipidologist and Chief Medical Officer of Precision Health Reports. With over three decades of experience, Dr. Cromwell breaks down why the traditional "calculated LDL" economy is failing patients and why we must look at the actual ApoB particle count to understand vascular risk.We explore the "perfect storm" of cardiometabolic disease—the intersection of insulin resistance, systemic inflammation, and atherogenic lipoproteins. Dr. Cromwell also reveals the LPIR score, a groundbreaking biomarker that can predict type 2 diabetes up to 20 years before blood sugar levels ever rise.*In this episode, we discuss:** The Cholesterol Economy: Why LDL-C is an outdated surrogate and how ApoB provides the true "bottle count" of risk.* Atherosclerosis 101: How particles penetrate the subendothelial layer and transform into foam cells.* The LPIR Score: Why this NMR-derived metric is the most powerful predictor of insulin resistance and incident diabetes.* Imaging Over Labs: Why a CAC score of zero can be a "false negative" and how CCTA or Carotid Ultrasound find the plaque that matters.* Lipoprotein(a): The genetic "poor hand" and why you only need to test it once in a lifetime.* Statin Intolerance: Creative ways to manage risk through combination therapy and the "Rule of Sixes."* The MVX & GlycA Scores: New ways to discriminate mortality risk independent of age or existing vascular disease.About Dr. William Cromwell: Dr. Cromwell is an Associate Professor of Lipidology at Wake Forest and a leading thinker in personalized medicine. His work focuses on integrating clinical history with advanced biomarkers to create highly individualized risk assessments.*Resources Mentioned:** Precision Health Reports: precisionhealthreports.com* MESA Study (Multi-Ethnic Study of Atherosclerosis)* Framingham Heart Study* CIMT vs. B-mode Ultrasound*Connect with Velocity Health:** Website: https://www.velocityhealthclinic.com* Instagram: https://www.instagram.com/velocity_health/* Twitter/X: https://x.com/join_velocity* Precision Medicine Consults: https://velocityhealthclinic.com/book-your-private-consultation/Disclaimer: This video is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding your specific health concerns.#HeartHealth #Lipidology #ApoB #InsulinResistance #Longevity #PrecisionMedicine #DrWilliamCromwell #Cholesterol #Biohacking #DiabetesPrevention #TheUltimateAsset
What this episode covers
Heart disease is the #1 killer in the world, but are we measuring the right markers?In this episode of The Ultimate Asset, Dr. Deep sits down with Dr. William Cromwell, a world-renowned lipidologist and Chief Medical Officer of Precision Health Reports. With over three decades of experience, Dr. Cromwell breaks down why the traditional "calculated LDL" economy is failing patients and why we must look at the actual ApoB particle count to understand vascular risk.We explore the "perfect storm" of cardiometabolic disease—the intersection of insulin resistance, systemic inflammation, and atherogenic lipoproteins. Dr. Cromwell also reveals the LPIR score, a groundbreaking biomarker that can predict type 2 diabetes up to 20 years before blood sugar levels ever rise.*In this episode, we discuss:** The Cholesterol Economy: Why LDL-C is an outdated surrogate and how ApoB provides the true "bottle count" of risk.* Atherosclerosis 101: How particles penetrate the subendothelial layer and transform into foam cells.* The LPIR Score: Why this NMR-derived metric is the most powerful predictor of insulin resistance and incident diabetes.* Imaging Over Labs: Why a CAC score of zero can be a "false negative" and how CCTA or Carotid Ultrasound find the plaque that matters.* Lipoprotein(a): The genetic "poor hand" and why you only need to test it once in a lifetime.* Statin Intolerance: Creative ways to manage risk through combination therapy and the "Rule of Sixes."* The MVX & GlycA Scores: New ways to discriminate mortality risk independent of age or existing vascular disease.About Dr. William Cromwell: Dr. Cromwell is an Associate Professor of Lipidology at Wake Forest and a leading thinker in personalized medicine. His work focuses on integrating clinical history with advanced biomarkers to create highly individualized risk assessments.*Resources Mentioned:** Precision Health Reports: precisionhealthreports.com* MESA Study (Multi-Ethnic Study of Atherosclerosis)* Framingham Heart Study* CIMT vs. B-mode Ultrasound*Connect with Velocity Health:** Website: https://www.velocityhealthclinic.com* Instagram: https://www.instagram.com/velocity_health/* Twitter/X: https://x.com/join_velocity* Precision Medicine Consults: https://velocityhealthclinic.com/book-your-private-consultation/Disclaimer: This video is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding your specific health concerns.#HeartHealth #Lipidology #ApoB #InsulinResistance #Longevity #PrecisionMedicine #DrWilliamCromwell #Cholesterol #Biohacking #DiabetesPrevention #TheUltimateAsset
NOW PLAYING
Reversing Vascular Plaque: The Truth About Cholesterol with Lipidologist Dr. William Cromwell
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m